Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post on X:
“Most practice-changing Abstract in EHA2025, in my opinion, might surprise some.
Cyclophosphamide is the new SoC for LGL Leukemia.
Kudos to authors for conducting a randomized trial in this ultra rare disease (n=150).”
More posts featuring Guilherme Perini.